SG11201406160QA - Method for producing reagent for antibody detection and use thereof - Google Patents

Method for producing reagent for antibody detection and use thereof

Info

Publication number
SG11201406160QA
SG11201406160QA SG11201406160QA SG11201406160QA SG11201406160QA SG 11201406160Q A SG11201406160Q A SG 11201406160QA SG 11201406160Q A SG11201406160Q A SG 11201406160QA SG 11201406160Q A SG11201406160Q A SG 11201406160QA SG 11201406160Q A SG11201406160Q A SG 11201406160QA
Authority
SG
Singapore
Prior art keywords
antibody detection
producing reagent
reagent
producing
antibody
Prior art date
Application number
SG11201406160QA
Inventor
Junichiro Futami
Kazuhiro Kakimi
Ryuji Maekawa
Masato Shiraki
Original Assignee
Junichiro Futami
Medinet Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Junichiro Futami, Medinet Co Ltd filed Critical Junichiro Futami
Publication of SG11201406160QA publication Critical patent/SG11201406160QA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
SG11201406160QA 2012-03-30 2013-03-29 Method for producing reagent for antibody detection and use thereof SG11201406160QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012082735 2012-03-30
PCT/JP2013/059692 WO2013147233A1 (en) 2012-03-30 2013-03-29 Method for producing reagent for antibody detection and use thereof

Publications (1)

Publication Number Publication Date
SG11201406160QA true SG11201406160QA (en) 2014-11-27

Family

ID=49260472

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201406160QA SG11201406160QA (en) 2012-03-30 2013-03-29 Method for producing reagent for antibody detection and use thereof

Country Status (8)

Country Link
US (2) US10822384B2 (en)
EP (1) EP2833143B1 (en)
JP (1) JP6168497B2 (en)
CN (1) CN104380106B (en)
AU (1) AU2013240942B2 (en)
SG (1) SG11201406160QA (en)
TW (1) TWI582424B (en)
WO (1) WO2013147233A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013240942B2 (en) * 2012-03-30 2018-07-05 Junichiro Futami Method for producing reagent for antibody detection and use thereof
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
FI3388075T3 (en) 2015-03-27 2023-08-18 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various tumors (seq id 25 - mrax5-003)
US11709165B2 (en) 2017-05-11 2023-07-25 Kawasaki Gakuen Educational Foundation Examination method for prediction of effect of treatment of cancer based on detection of cancer/testis antibodies
GB201803750D0 (en) * 2018-03-08 2018-04-25 Immunocore Ltd Method
CN111647066B (en) * 2020-07-01 2020-12-18 维肽瀛(上海)生物技术有限公司 WT1 polypeptide tumor inhibitor

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3225468B2 (en) 1992-08-28 2001-11-05 ダイナボット株式会社 Antibody measurement reagent
US6589736B1 (en) * 1994-11-22 2003-07-08 The Trustees Of Boston University Photocleavable agents and conjugates for the detection and isolation of biomolecules
WO2002010760A1 (en) * 2000-07-27 2002-02-07 Kyowa Medex Co., Ltd Method of immunity examination with insoluble carrier particle and reagent therefor
JP4833831B2 (en) * 2003-03-31 2011-12-07 ウイミンズ、アンド、チルドランズ、ホスピトル Multiple screening for lysosomal storage diseases (LDS)
JP3960614B2 (en) 2003-08-31 2007-08-15 株式会社イムノディア Anti-peptide antibody measurement method and vaccine candidate selection method for peptide vaccine
JP2005098877A (en) 2003-09-25 2005-04-14 Hitachi Software Eng Co Ltd Antibody detector, its manufacturing method, and antibody detecting method
JP4628418B2 (en) * 2004-03-08 2011-02-09 アメリカ合衆国 Autoantibody detection for cancer diagnosis
EP1650297B1 (en) * 2004-10-19 2011-04-13 Samsung Electronics Co., Ltd. Method and apparatus for the rapid disruption of cells or viruses using micro magnetic beads and laser
CN100406889C (en) * 2005-07-15 2008-07-30 北京倍爱康生物技术股份有限公司 Magnetic separation enzymatic chemical luminous immune detection method of human thyroglobulin antibody
JP4660431B2 (en) * 2006-06-22 2011-03-30 株式会社アルバック Biological material detection / recovery method and apparatus, and biological material analysis method
FR2908414B1 (en) * 2006-11-13 2012-01-20 Centre Nat Rech Scient IMMOBILIZATION OF MEMBRANE PROTEINS ON A SUPPORT THROUGH AN AMPHIPHILE MOLECULE
JP2008233007A (en) * 2007-03-23 2008-10-02 Osaka Industrial Promotion Organization Diagnosis kit and determination method for malignant lymphoma
CN101452001B (en) * 2007-12-06 2013-07-24 王颖 Quantitative determination RBP4 kit by chemiluminescence magnetic enzymoimmune method
JP5326454B2 (en) 2008-09-18 2013-10-30 大同特殊鋼株式会社 Batch type heat treatment furnace
CN101403747B (en) * 2008-11-07 2012-08-29 浙江伊利康生物技术有限公司 Alexin 3 detection reagent
CN101551394A (en) 2009-05-13 2009-10-07 郑州安图绿科生物工程有限公司 Method for detecting third type hepatitis virus antibody by using magnetic micro-particle as transporting species
JP5713006B2 (en) 2010-03-25 2015-05-07 国立大学法人 岡山大学 Reversible cationization agent and solubilization method of thiosulfonate compound, protein and / or peptide
AU2013240942B2 (en) * 2012-03-30 2018-07-05 Junichiro Futami Method for producing reagent for antibody detection and use thereof

Also Published As

Publication number Publication date
CN104380106A (en) 2015-02-25
JPWO2013147233A1 (en) 2015-12-14
EP2833143A4 (en) 2015-11-11
WO2013147233A1 (en) 2013-10-03
EP2833143B1 (en) 2019-04-24
US20210032302A1 (en) 2021-02-04
EP2833143A1 (en) 2015-02-04
TWI582424B (en) 2017-05-11
US20150064801A1 (en) 2015-03-05
AU2013240942B2 (en) 2018-07-05
US10822384B2 (en) 2020-11-03
TW201400814A (en) 2014-01-01
AU2013240942A1 (en) 2014-11-13
JP6168497B2 (en) 2017-07-26
CN104380106B (en) 2017-02-22

Similar Documents

Publication Publication Date Title
IL257714B (en) Systems and methods for multiple analyte analysis
HK1207422A1 (en) Device and method for detection of analytes
EP2917734A4 (en) System and method for serum based cancer detection
EP2884270A4 (en) Biomolecule detection method, biomolecule detection device and analysis device
EP2812676A4 (en) Methods and systems for analyzing samples
EP2888274A4 (en) Device and method for performing blood thromboelastographic assays by magnetic sensing
HRP20190030T1 (en) Method of purifying an antibody
HK1168649A1 (en) Method and device for assay determination
EP2861623A4 (en) Novel antibody specific for clec14a and uses thereof
EP2909346A4 (en) Method and system for sample preparation
PL2633914T3 (en) Pipetting device and method for its production
PL2901131T3 (en) Arrangement and method for producing analysis samples
EP2902782A4 (en) Immunological detection process and reagent for immunological detection process
EP2900265A4 (en) Anti-uroplakin ii antibodies systems and methods
EP2899538A4 (en) Biosensor and method for manufacturing biosensor
SG11201406160QA (en) Method for producing reagent for antibody detection and use thereof
HK1203354A1 (en) Anti-theophylline antibodies and methods of use
EP2833141A4 (en) Immunological analysis method and reagent
PL2823309T3 (en) Method and device for detecting analytes
IL234932B (en) Method and structure for chemical analysis
HK1196982A1 (en) Calibration reagent and method
EP2841943C0 (en) Method for characterizing and/or determining samples
PL2981824T3 (en) Method for detecting asyn-specific antibodies in a biological sample
EP2919010A4 (en) Method for testing for nephritis-lesion sites and reagent therefor
GB201217783D0 (en) Analyte detection device and method